Five-Year Sustained Response to Nivolumab in Hepatocellular Carcinoma Following Serious Immune-Related Hepatitis
AuthID
P-018-3Z1
P-018-3Z1
© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service